ICARES Medicus, Inc. (6612.TWO)
- Previous Close
117.00 - Open
116.00 - Bid 118.00 x --
- Ask 119.50 x --
- Day's Range
116.00 - 119.00 - 52 Week Range
88.50 - 177.00 - Volume
6,048 - Avg. Volume
46,277 - Market Cap (intraday)
5.126B - Beta (5Y Monthly) --
- PE Ratio (TTM)
40.07 - EPS (TTM)
2.97 - Earnings Date --
- Forward Dividend & Yield 0.20 (0.17%)
- Ex-Dividend Date Jul 8, 2024
- 1y Target Est
--
ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments for implantable and interventional medical devices. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei City, Taiwan.
www.icaresmedicus.comRecent News: 6612.TWO
View MorePerformance Overview: 6612.TWO
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6612.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6612.TWO
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
39.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.02
Price/Book (mrq)
2.92
Enterprise Value/Revenue
5.21
Enterprise Value/EBITDA
16.80
Financial Highlights
Profitability and Income Statement
Profit Margin
12.79%
Return on Assets (ttm)
3.62%
Return on Equity (ttm)
4.44%
Revenue (ttm)
996.44M
Net Income Avi to Common (ttm)
127.4M
Diluted EPS (ttm)
2.97
Balance Sheet and Cash Flow
Total Cash (mrq)
726.95M
Total Debt/Equity (mrq)
46.49%
Levered Free Cash Flow (ttm)
-206.56M